Cargando…
Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial
BACKGROUND: The Fas apoptotic pathway has been implicated in type 2 diabetes and cardiovascular disease. Although a polymorphism (rs7138803; G > A) near the Fas apoptotic inhibitory molecule 2 (FAIM2) locus has been related to obesity, its association with other cardiovascular risk factors and di...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922966/ https://www.ncbi.nlm.nih.gov/pubmed/24393375 http://dx.doi.org/10.1186/1475-2840-13-5 |
_version_ | 1782303540353433600 |
---|---|
author | Corella, Dolores Sorlí, Jose V González, José I Ortega, Carolina Fitó, Montserrat Bulló, Monica Martínez-González, Miguel Angel Ros, Emilio Arós, Fernando Lapetra, José Gómez-Gracia, Enrique Serra-Majem, Lluís Ruiz-Gutierrez, Valentina Fiol, Miquel Coltell, Oscar Vinyoles, Ernest Pintó, Xavier Martí, Amelia Saiz, Carmen Ordovás, José M Estruch, Ramón |
author_facet | Corella, Dolores Sorlí, Jose V González, José I Ortega, Carolina Fitó, Montserrat Bulló, Monica Martínez-González, Miguel Angel Ros, Emilio Arós, Fernando Lapetra, José Gómez-Gracia, Enrique Serra-Majem, Lluís Ruiz-Gutierrez, Valentina Fiol, Miquel Coltell, Oscar Vinyoles, Ernest Pintó, Xavier Martí, Amelia Saiz, Carmen Ordovás, José M Estruch, Ramón |
author_sort | Corella, Dolores |
collection | PubMed |
description | BACKGROUND: The Fas apoptotic pathway has been implicated in type 2 diabetes and cardiovascular disease. Although a polymorphism (rs7138803; G > A) near the Fas apoptotic inhibitory molecule 2 (FAIM2) locus has been related to obesity, its association with other cardiovascular risk factors and disease remains uncertain. METHODS: We analyzed the association between the FAIM2-rs7138803 polymorphism and obesity, blood pressure and heart rate in 7,161 participants (48.3% with type 2 diabetes) in the PREDIMED study at baseline. We also explored gene-diet interactions with adherence to the Mediterranean diet (MedDiet) and examined the effects of the polymorphism on cardiovascular disease incidence per diabetes status after a median 4.8-year dietary intervention (MedDiet versus control group) follow-up. RESULTS: We replicated the association between the FAIM2-rs7138803 polymorphism and greater obesity risk (OR: 1.08; 95% CI: 1.01-1.16; P = 0.011; per-A allele). Moreover, we detected novel associations of this polymorphism with higher diastolic blood pressure (DBP) and heart rate at baseline (B = 1.07; 95% CI: 0.97-1.28 bmp in AA vs G-carriers for the whole population), that remained statistically significant even after adjustment for body mass index (P = 0.012) and correction for multiple comparisons. This association was greater and statistically significant in type-2 diabetic subjects (B = 1.44: 95% CI: 0.23-2.56 bmp; P = 0.010 for AA versus G-carriers). Likewise, these findings were also observed longitudinally over 5-year follow-up. Nevertheless, we found no statistically significant gene-diet interactions with MedDiet for this trait. On analyzing myocardial infarction risk, we detected a nominally significant (P = 0.041) association in type-2 diabetic subjects (HR: 1.86; 95% CI:1.03-3.37 for AA versus G-carriers), although this association did not remain statistically significant following correction for multiple comparisons. CONCLUSIONS: We confirmed the FAIM2-rs7138803 relationship with obesity and identified novel and consistent associations with heart rate in particular in type 2 diabetic subjects. Furthermore, our results suggest a possible association of this polymorphism with higher myocardial infarction risk in type-2 diabetic subjects, although this result needs to be replicated as it could represent a false positive. |
format | Online Article Text |
id | pubmed-3922966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39229662014-02-14 Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial Corella, Dolores Sorlí, Jose V González, José I Ortega, Carolina Fitó, Montserrat Bulló, Monica Martínez-González, Miguel Angel Ros, Emilio Arós, Fernando Lapetra, José Gómez-Gracia, Enrique Serra-Majem, Lluís Ruiz-Gutierrez, Valentina Fiol, Miquel Coltell, Oscar Vinyoles, Ernest Pintó, Xavier Martí, Amelia Saiz, Carmen Ordovás, José M Estruch, Ramón Cardiovasc Diabetol Original Investigation BACKGROUND: The Fas apoptotic pathway has been implicated in type 2 diabetes and cardiovascular disease. Although a polymorphism (rs7138803; G > A) near the Fas apoptotic inhibitory molecule 2 (FAIM2) locus has been related to obesity, its association with other cardiovascular risk factors and disease remains uncertain. METHODS: We analyzed the association between the FAIM2-rs7138803 polymorphism and obesity, blood pressure and heart rate in 7,161 participants (48.3% with type 2 diabetes) in the PREDIMED study at baseline. We also explored gene-diet interactions with adherence to the Mediterranean diet (MedDiet) and examined the effects of the polymorphism on cardiovascular disease incidence per diabetes status after a median 4.8-year dietary intervention (MedDiet versus control group) follow-up. RESULTS: We replicated the association between the FAIM2-rs7138803 polymorphism and greater obesity risk (OR: 1.08; 95% CI: 1.01-1.16; P = 0.011; per-A allele). Moreover, we detected novel associations of this polymorphism with higher diastolic blood pressure (DBP) and heart rate at baseline (B = 1.07; 95% CI: 0.97-1.28 bmp in AA vs G-carriers for the whole population), that remained statistically significant even after adjustment for body mass index (P = 0.012) and correction for multiple comparisons. This association was greater and statistically significant in type-2 diabetic subjects (B = 1.44: 95% CI: 0.23-2.56 bmp; P = 0.010 for AA versus G-carriers). Likewise, these findings were also observed longitudinally over 5-year follow-up. Nevertheless, we found no statistically significant gene-diet interactions with MedDiet for this trait. On analyzing myocardial infarction risk, we detected a nominally significant (P = 0.041) association in type-2 diabetic subjects (HR: 1.86; 95% CI:1.03-3.37 for AA versus G-carriers), although this association did not remain statistically significant following correction for multiple comparisons. CONCLUSIONS: We confirmed the FAIM2-rs7138803 relationship with obesity and identified novel and consistent associations with heart rate in particular in type 2 diabetic subjects. Furthermore, our results suggest a possible association of this polymorphism with higher myocardial infarction risk in type-2 diabetic subjects, although this result needs to be replicated as it could represent a false positive. BioMed Central 2014-01-06 /pmc/articles/PMC3922966/ /pubmed/24393375 http://dx.doi.org/10.1186/1475-2840-13-5 Text en Copyright © 2014 Corella et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Corella, Dolores Sorlí, Jose V González, José I Ortega, Carolina Fitó, Montserrat Bulló, Monica Martínez-González, Miguel Angel Ros, Emilio Arós, Fernando Lapetra, José Gómez-Gracia, Enrique Serra-Majem, Lluís Ruiz-Gutierrez, Valentina Fiol, Miquel Coltell, Oscar Vinyoles, Ernest Pintó, Xavier Martí, Amelia Saiz, Carmen Ordovás, José M Estruch, Ramón Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial |
title | Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial |
title_full | Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial |
title_fullStr | Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial |
title_full_unstemmed | Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial |
title_short | Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial |
title_sort | novel association of the obesity risk-allele near fas apoptotic inhibitory molecule 2 (faim2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the predimed trial |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922966/ https://www.ncbi.nlm.nih.gov/pubmed/24393375 http://dx.doi.org/10.1186/1475-2840-13-5 |
work_keys_str_mv | AT corelladolores novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT sorlijosev novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT gonzalezjosei novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT ortegacarolina novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT fitomontserrat novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT bullomonica novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT martinezgonzalezmiguelangel novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT rosemilio novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT arosfernando novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT lapetrajose novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT gomezgraciaenrique novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT serramajemlluis novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT ruizgutierrezvalentina novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT fiolmiquel novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT coltelloscar novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT vinyolesernest novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT pintoxavier novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT martiamelia novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT saizcarmen novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT ordovasjosem novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial AT estruchramon novelassociationoftheobesityriskallelenearfasapoptoticinhibitorymolecule2faim2genewithheartrateandstudyofitseffectsonmyocardialinfarctionindiabeticparticipantsofthepredimedtrial |